St. Jude Medical, Inc.
Devices company gets clearance to buy Advanced Neuromodulation Systems
Published in Mental Health Law Weekly, December 17th, 2005
This approval, together with the previously announced expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, satisfies the antitrust approval condition set forth in the parties' merger agreement. No other regulatory approvals are required for the merger.
On October 18, 2005, St. Jude Medical commenced an all-cash tender offer for all of the outstanding shares of ANS common stock at a price of $61.25 per share. The...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Mental Health Law Weekly
More Articles from Mental Health Law Weekly
- American Academy of Neurology
Professional society elaborates expert witness guidelines - RIKEN Brain Science Institute
ASCL1 may be associated with Parkinson disease - Scripps Research Institute, La Jolla
Acamprosate is effective in treatment of alcohol dependence - Signet Laboratories, Inc.
Availability of polyclonal hepsin antibody announced - U.S. National Institute of Mental Health
Anorexia nervosa involves complex neuronal circuitries that may be similar in obesity - Amarin Corp. plc
Significant neuroprotective effects of Miraxion reported - More from this issue of Mental Health Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
